<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310866</url>
  </required_header>
  <id_info>
    <org_study_id>R/17.08.102</org_study_id>
    <nct_id>NCT03310866</nct_id>
  </id_info>
  <brief_title>Macintosh Laryngoscope Assisted Fiberoptic Intubation</brief_title>
  <official_title>Macintosh Laryngoscope Assisted Flexible Fiber Optic Endotracheal Intubation Versus Classic Fiber Optic Laryngoscope Alone Endotracheal Intubation for Modified Mallampati III&amp;IV Patients : A Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During fiberoptic endotracheal intubation, the perfect airway exposure produced by the
      classic curved Macintosh laryngoscope in place of head tilt -chin lift-jaw thrust maneuver
      may increase the accuracy and produce rapid direct vocal cord access in a short time under
      Inhalation anesthesia to maintain the respiratory drive for grade III&amp;VI Modified Mallampati
      .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Managing difficult airway is critical for anesthesia-related morbidity and mortality.
      Fiberoptic laryngoscope is a reliable tool for endotracheal intubation in difficult airway
      cases (Modified Mallampatti III&amp;IV), but always there is difficulty to visualize the glottis
      due to airway tendency to collapse, classically a specific fiberoptic airway with a side way
      is used and it may added head tilt chin lift jaw thrust. A new technique utilizing
      sevoflurane anesthesia to maintain the respiratory drive without exposing the patient to the
      stress of the awake airway instrumentation. Simultaneous utilization of both Macintosh curved
      laryngoscope and Fiberoptic bronchoscope during Endotracheal intubation (ETT) will be
      examined for the efficacy during difficult airway management.

      All patients should be examined preoperatively for the scoring Modified Mallampati or non
      tongue protrusion mallampati (NT-MMT) airway score. The pharyngeal structures were then
      evaluated and the best view (lowest class) was recorded. The classification follows m-MMT and
      is as follows: class 1, full visibility of tonsils, uvula, and soft palate; class 2,
      visibility of hard and soft palate, upper portion of tonsils and uvula; class 3, visibility
      of the soft and hard palate and base of the uvula; and class 4, visibility of only the hard
      palate, class III or IV patients were included in the study. Inhalational anesthesia use
      maintains the respiratory drive of the patient allowing less stressful technique.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intubation time</measure>
    <time_frame>during intubation</time_frame>
    <description>time from introduction of the tip of the fiber optic laryngoscope till insertion of the tube in the laryngeal inlet down in the trachea in seconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lower jaw relaxation</measure>
    <time_frame>during intubation</time_frame>
    <description>(Relaxed= 0, not fully=1, poor= 2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vocal cord position</measure>
    <time_frame>during intubation</time_frame>
    <description>(Abducted= 0, Intermediate opening= 1, Closed= 2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck movements</measure>
    <time_frame>during intubation and cuff inflation</time_frame>
    <description>for endotracheal tube or cuff inflation (no=0, slight= 1, vigorous= 2),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cough</measure>
    <time_frame>during intubation and cuff inflation</time_frame>
    <description>(absent= 0, present=1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1st trial success rate</measure>
    <time_frame>during intubation</time_frame>
    <description>in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of trails</measure>
    <time_frame>during intubation</time_frame>
    <description>(1st trial=1, 2nd trial= 2, 3rd trial= 3)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial Blood pressure (MBP)</measure>
    <time_frame>during intubation till 5 minutes after intubation</time_frame>
    <description>basal, every minute during intubation, 1, 3, 5 minutes after intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean heart rate (HR)</measure>
    <time_frame>during intubation till 5 minutes after intubation</time_frame>
    <description>basal, every minute during intubation, 1, 3, 5 minutes after intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>desaturation (SpO2)</measure>
    <time_frame>during intubation</time_frame>
    <description>oxygen saturation &lt;90% .(Yes=1, No= 0)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Difficult Intubation</condition>
  <arm_group>
    <arm_group_label>fiberoptic, airway</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Classical fiberoptic intubation assisted by side fenestrated airway and head tilt- chin lift- jaw thrust by 2 anesthetist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fiberoptic, Machintosh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral Fiberoptic bronchoscopic intubation assisted by Macintosh Laryngoscope, by 2 anesthetist</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fiberoptic, airway</intervention_name>
    <description>classic fiberoptic bronchoscope, fenstrated airway</description>
    <arm_group_label>fiberoptic, airway</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fiberoptic, Machintosh</intervention_name>
    <description>oral fiberoptic brochoscopic, Machintosh laryngoscope</description>
    <arm_group_label>fiberoptic, Machintosh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with Modified Mallampati (NT-MMT) airway score III,VI

          -  American Society of Anaesthesiologists (ASA) physical class I-III

          -  Scheduled for elective cancer surgery under general anesthesia

        Exclusion Criteria:

          -  Modified Mallampati I,II Airway scored patients.

          -  History of upper airway surgery.

          -  Patients with serious deformities of the mandible, maxilla, tongue, pharynx or larynx.

          -  Patients with a history of significant cardiac and pulmonary diseases,

          -  Obesity with BMI &gt;40,

          -  Epilepsy, pregnancy, mental disease, neurological psychological disorders.

          -  Communication barrier.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed A. Ghanem principle investigator, MD</last_name>
    <phone>002 01067883998</phone>
    <email>mohamed.abdel_latif@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alaa Mazy, MD</last_name>
    <phone>002 01140065052</phone>
    <email>alaa_mazy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oncolgy Center, Mansoura University,</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed A. Ghanem, MD</last_name>
      <phone>002 01067883998</phone>
      <email>mohamed.abdel_latif@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Alaa Mazy, MD</last_name>
      <phone>002 01140065052</phone>
      <email>alaa_mazy@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2017</study_first_submitted>
  <study_first_submitted_qc>October 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>after publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

